Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.28
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Jan 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
99
100
Next >
Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years
↗
August 21, 2025
HC Wainwright backs Achieve Life Sciences with a Buy rating as cytisinicline nears potential 2026 FDA approval, targeting a large smoking cessation market.
Via
Benzinga
Looking for the most active stocks in the S&P500 index on Thursday?
↗
August 21, 2025
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Thursday and uncover the stocks that are leading the way in terms of trading volume and market...
Via
Chartmill
This Is What Whales Are Betting On Pfizer
↗
August 21, 2025
Via
Benzinga
CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans
↗
August 21, 2025
CVS rejected coverage of Gilead's new HIV prevention drug Yeztugo, citing regulatory and financial factors, while facing nearly $290 million in Medicare overcharge penalties.
Via
Benzinga
How Do Investors Really Feel About Pfizer?
↗
August 14, 2025
Via
Benzinga
My Top Dividend-Paying, Deep-Value Stock to Buy in August
↗
August 20, 2025
You won't find many stocks with a juicier dividend and more attractive valuation than this big pharma stock.
Via
The Motley Fool
Topics
Earnings
Intellectual Property
2 S&P 500 Stocks to Own for Decades and 1 We Ignore
August 20, 2025
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...
Via
StockStory
Topics
Stocks
Q2 Earnings Roundup: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Segment
August 19, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how generic pharmaceuticals stocks fared in Q2, starting with...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Viking Therapeutics Plummets as Oral Obesity Drug Trial Raises Tolerability Concerns
August 19, 2025
San Diego, CA – Viking Therapeutics (NASDAQ: VKTX) experienced a dramatic stock decline today following the release of disappointing clinical trial results for its highly anticipated oral tablet...
Via
MarketMinute
Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market
August 19, 2025
Comtex News Network, Inc. is a content specialist offering actionable news distribution, global syndication, and traffic for your content
Via
News Direct
Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market
August 19, 2025
Via
AB Newswire
Is Pfizer's 6.8%-Yielding Dividend Too Good to Be True?
↗
August 19, 2025
Pfizer's yield is high, and so too is its payout ratio.
Via
The Motley Fool
3 Hyped Up Stocks That Fall Short
August 19, 2025
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...
Via
StockStory
Intel, Nvidia, Twilio, Palo Alto Networks, Pfizer: What Sparked Heavy After-Hours Trading In These 5 Stocks?
↗
August 19, 2025
Intel continued its winning run amid news of new strategic investment, while Nvidia saw activity as traders geared up for its quarterly results due next week.
Via
Stocktwits
Predicting the Next Rule Breaker Buyout
↗
August 19, 2025
Having a stock you own get acquired at a premium feels good at first, but what about the long-term gains that will be left behind when your chips are off the table?
Via
The Motley Fool
Topics
Artificial Intelligence
These S&P500 stocks are the most active in today's session
↗
August 18, 2025
Let's have a look at what is happening on the US markets on Monday. Below you can find the most active S&P500 stocks in today's session.
Via
Chartmill
Profusa Inc (NASDAQ: PFSA) Establishes a distributor partner in Spain for Lumee Oxygen platform
August 18, 2025
Via
AB Newswire
These 3 Dividend Stocks Have Yields Above 5%, Plus They Raise Their Payouts Every Year
↗
August 18, 2025
These three businesses have been raising their payouts for at least 16 consecutive years.
Via
The Motley Fool
Winners And Losers Of Q2: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks
August 17, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q2, starting with...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
2 Top Dividend Stocks to Buy on the Dip
↗
August 16, 2025
These blue chip healthcare stocks could still deliver strong long-term returns.
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.
↗
August 16, 2025
Viking Therapeutics' dual-formulation obesity drug could be the David to Lilly's Goliath.
Via
The Motley Fool
Topics
Economy
Pfizer's Investigational Drug Flunks Late-Stage For Sickle Cell Disease
↗
August 15, 2025
Pfizer's Phase 3 trial of inclacumab in sickle cell disease misses its main goal but shows safety, with further updates on other drugs planned.
Via
Benzinga
3 Long-Term Dividend Buys You Can Get for Under $50
↗
August 15, 2025
Discover three undervalued dividend stocks under $50 that offer income, growth potential, and strong total returns for value investors
Via
MarketBeat
After a Strong Quarterly Result, Is It Finally Safe to Buy Pfizer Stock Again?
↗
August 15, 2025
Pfizer beat expectations last quarter and it raised its guidance.
Via
The Motley Fool
Topics
World Trade
Celcuity Expenses Jump 81 Percent
↗
August 14, 2025
Via
The Motley Fool
Cautious Start On Dalal Street As Traders Eye Expiry, WPI Inflation Data; Muthoot Hits Record High, Infosys Gains on Versent Deal
↗
August 14, 2025
Markets watch for the Trump–Putin meeting tomorrow that could impact Russia–Ukraine peace talks. Analysts see 24,600 as a make-or-break level for Nifty ahead of weekly expiry volatility.
Via
Stocktwits
Topics
Economy
Government
Most active S&P500 stocks in Wednesday's session
↗
August 13, 2025
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Wednesday and uncover the stocks that are leading the way in terms of trading volume and market...
Via
Chartmill
HC Wainwright Doubles Price Target On Insmed After Brinsupri Approval: Retail Expects Stock To Hit $150 By End Of Week
↗
August 13, 2025
The analyst sees Insmed as "poised to join the ranks" of Roche's Genentech and Pfizer's Seagen as companies that have successfully deployed the "pipeline-in-a-pill" strategy.
Via
Stocktwits
3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer
↗
August 13, 2025
This big pharma company's juicy dividend is looking even more attractive.
Via
The Motley Fool
Topics
Earnings
Bristol-Myers Squibb’s Q2 Earnings Call: Our Top 5 Analyst Questions
August 13, 2025
Bristol-Myers Squibb’s second quarter saw flat overall sales, but the company surpassed Wall Street expectations for both revenue and non-GAAP profit, with operating margin improving year on year....
Via
StockStory
Topics
Earnings
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
